Principles of adoptive T cell therapy in cancer
- PMID: 30187086
- DOI: 10.1007/s00281-018-0703-z
Principles of adoptive T cell therapy in cancer
Abstract
Adoptive cell therapy (ACT) utilizing either tumor-infiltrating lymphocyte (TIL)-derived T cells or T cells genetically engineered to express tumor recognizing receptors has emerged as a powerful and potentially curative therapy for several cancers. Many ACT-based therapies have recently entered late-phase clinical testing, with several T cell therapies already achieving regulatory approval for the treatment of patients with B cell malignancies. In this review, we briefly outline the principles of adoptively transferred T cells for the treatment of cancer.
Keywords: Adoptive cell therapy; Cancer immunotherapy; Chimeric antigen receptor; T cells; Tumor-infiltrating lymphocytes.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
